Smarter Cervical Cancer Screening: Improving Outcomes While Reducing Costs
Cervical cancer remains one of the most preventable forms of cancer, yet it continues to affect thousands of women every year. Advances in vaccination and screening …
Universal Access to Prenatal Screening: A Belgian Success Story
For decades, prenatal screening relied on a combination of ultrasound measurements, blood tests, and risk calculations. While these methods provided valuable information, they also came with limitations: missed diagnoses, …
Beyond Diagnosis: How Smarter Testing Can Improve Pregnancy Care
Preeclampsia is one of the most serious complications in pregnancy. Yet diagnosing it isn't always straightforward. Symptoms can be vague, overlap with other conditions, or appear before the disease is fully developed.
Earlier Detection, Better Outcomes: Rethinking Pre-Eclampsia Screening
Pre-eclampsia is one of the most serious complications during pregnancy, affecting both maternal and neonatal health. While effective preventative measures exist, their success depends largely on identifying high-risk pregnancies early enough to intervene.
Novartis Radioligand Therapy Launch in Belgium
Bringing innovative prostate cancer therapy to Belgium first and designing the national model that could scale.
€1.5M EIT Health / Horizon 2020 Grant
A multi-stakeholder coalition that outlived the grant — 1 of a handful selected from 276 applicants.
HPV Primary Screening, Belgium
Belgium's national shift from cytology to HPV primary screening, reimbursement secured.
NIPT Reimbursement, Belgium
World's first universal NIPT reimbursement and a reference model across Europe.